Arthritis drug cuts death risk in high-risk patients. Mu variant’s escape from antibodies may inform vaccine research
The WHO include interleukin-6 receptor blockers, lifesaving in patients who are severely or critically ill with Covid-19, especially when administered alongside corticosteroids.
Developing pills to fight the virus early in the course of infection, potentially saving many lives in the years to come.
Online medicine purchases gain ground in China. Though the surge was largely due to the Covid-19 epidemic, the trend has continued afterward. Convenience, timely deliveries and easy access drawing more consumers.
From condoms that self-lubricate to ones with in-built medication that protects against STDs, the contraception of the future is already in development.
By using waste products we could turn it into bandages for post-surgery, enhancing the speedy recovery of wounds to reduce the chances of infections.
The EMA has issued a positive opinion for the company’s investigational Covid-19 antibody cocktail casirivimab with imdevimab.
Drug overdoses of all kinds killed nearly 84,000 people in the U.S. from August 2019 to July 2020. Opioids accounted for more than 61,000, or 73%, of those deaths.
Commonly available oral supplements, such as zinc, ascorbic acid (ie, vitamin C) and vitamin D have been proposed to reduce the duration and severity of viral infections by boosting immune response. A research question worth evaluating.
Hoarding vaccines is not just immoral, but also medically self-defeating. Vaccine nationalism harms everyone and protects no one.
The spray works by delivering an antiviral into the nasal cavity, which coats the novel coronavirus, rendering it inactive in both the user and other individuals to which it may spread through coughing.
Better appreciating the ties between immunity and the nervous system could be central to understanding Covid-19 and to preventing it.
We assume oxygen will always be available. When it is not we quickly lose our breath, our focus, and perhaps our life. Medical oxygen is often a critical intervention for both pneumonia and Covid-19. In fact one of the most essential medicines we have.
Anti-cytokine therapy curbs IBD symptoms by normalizing reduced or elevated ACE2 levels. Infliximab may have potential for treating the more severe forms of Covid-19
Tamoxifen and Ilomastat alongside Amlodipine are already approved and could be immediately deployed to Covid-19 patients if proven effective.
By binding to the spike protein, the molecule she found can potentially prevent virus entry into the host cell, and can be used in creating a potential drug to cure Covid-19.
Another nice thing about monoclonal antibodies: they work immediately. It’s not like a vaccine that your body has to make a response. This is the response
Corticosteroids should now be the first-line treatment for critically ill patients, the authors said. The only other drug shown to be effective in seriously ill patients, and only modestly at that, is remdesivir.
Metformin is a widely available anti-diabetic agent that has an excellent safety profile, and clinical and preclinical data suggest metformin may offer cardiopulmonary protection in Covid-19 via enhanced ACE2 expression.
Development of monoclonal antibodies to target the virus has been endorsed by leading scientists. Anthony Fauci called them almost a sure bet against Covid-19.
In a test of antiviral effectiveness against the virus that causes Covid-19, an extract from edible seaweeds substantially outperformed remdesivir
Interferon (beta) seems to be news of the day. I plan to cover Sweden in more detail soon, there was just no time here to make a case.
Patients with severe COVID-19-associated cytokine storm syndrome (CSS) whether an intensive course of glucocorticoids with or without tocilizumab accelerates clinical improvement, reduces mortality and prevents invasive mechanical ventilation.
Remdesivir, van oorsprong een ebolaremmer, is onder voorwaarden goedgekeurd door de Europese medicijnautoriteiten (25.06.2020)
Remdesivir: initial findings are a step forward on the road to developing effective therapy for SARS-CoV-2 infections and, as such, are an important advance.
The British government announced on Tuesday that dexamethasone is to be used on COVID-19 patients from this afternoon (06.16.2020)